Will Alector (ALEC) Report Negative Q4 Earnings? What You Should KnowZacks Investment Research • 02/17/22
Alector Announces Appointment of Marc Grasso, M.D., as Chief Financial OfficerGlobeNewsWire • 02/07/22
Alector (ALEC) Surges 8%: Is This an Indication of Further Gains?Zacks Investment Research • 02/01/22
Alector Announces Appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and DevelopmentGlobeNewsWire • 12/15/21
Alzamend Neuro Announces Date for Delivery of Topline Data for Phase 1 First-in-Human Clinical Trial for AL001 for Dementia Related to Alzheimer'sBusiness Wire • 11/30/21
Alector Presents Encouraging New AL001 Data from the Symptomatic FTD-GRN Cohort of INFRONT-2 Phase 2 Open-label Clinical StudyGlobeNewsWire • 11/12/21
Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer's 36th Annual MeetingGlobeNewsWire • 11/12/21
Alector to Present New Data from Multiple Pipeline Programs at 2021 CTAD Conference and SITC Annual MeetingGlobeNewsWire • 11/03/21
Alector Stock Falls After Flashing 12-Month Data From Mid-Stage Trial In Frontotemporal Dementia PatientsBenzinga • 07/29/21
Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin MutationGlobeNewsWire • 07/29/21
Alector to Present New Data from Frontotemporal Dementia and Alzheimer's Disease Programs at the 2021 Alzheimer's Association International ConferenceGlobeNewsWire • 07/21/21